May 2017

Feature

Research Reports

The Impact of a Multidisciplinary Care Coordination Protocol On Patient-Centered Outcomes at an Academic Medical Center

05/12/2017

Abstract: Effective coordination of care has been associated with improved performance on patient-centered measures of care quality. A standardized protocol for conducting multidisciplinary rounds (MDR) can improve...

...

05/12/2017

Journal of Clinical Pathways

Research Reports

Cost-Effectiveness of a Patient Navigation Program for Colorectal Cancer Screening

05/12/2017

Andrea Dwyer , BS;

R. Mark Gritz , PhD;

Yvonne Kellar-Guenther , PhD;

Whitney C. Rhodes , PhD, MSPA;

Arnold H. Levinson , PhD, MJ;

Abstract: Patient navigators (PNs) support colorectal screening through increased attendance and improved bowel preparation and are now frequently embedded in primary care settings. In order to determine whether...

...

05/12/2017

Journal of Clinical Pathways

Column

Pharma Insights

What Does New Payer Research on Expected Biosimilar Management Mean to Others?

05/12/2017

Larry Blandford , PharmD;

Although the biosimilar era has officially launched, only one agent has entered the market as of April 2017. That would be Zarxio1, approved in March 2015 as a biosimilar for the market-leading granulocyte...

...

05/12/2017

Journal of Clinical Pathways

Clinical Pathways GPS

The Next 1361 Days and How They Will Impact Clinical Pathways

05/12/2017

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Over the course of the Trump Administration’s first 100 days, the president and members of Congress have introduced health care reform legislation that aims to profoundly change the ways medicine is practiced—and...

Over...

05/12/2017

Journal of Clinical Pathways

Insights

Interview

Palliative Care Claims Its Place in Oncology Practice

05/12/2017

JCP Editors

Proper care choices for patients with advanced cancers remains an open question in the oncology community. Despite limited life expectancies, patients whose diseases have reached advanced states often continue to...

Proper...

05/12/2017

Journal of Clinical Pathways

Interview

Managing Costs Across the Cancer Care Continuum

05/12/2017

JCP Editors

Few medical expenditures are costlier than a cancer diagnosis. Cancer-associated medical costs accounted for approximately $88 billion in health care spending in 2014, according to data from the Agency for Healthcare...

Few...

05/12/2017

Journal of Clinical Pathways

Department

Conference Preview

Conference Preview - American Society of Clinical Oncology Annual Meeting

05/12/2017

JCP Editors

Chicago, IL; June 2-6, 2017 ----- The ASCO Annual Meeting is undoubtedly the premier gathering of oncology professionals from the United States and abroad, and a fertile ground for the presentation of scientific...

...

05/12/2017

Journal of Clinical Pathways

Research in Review

PARP-1 Measurement Guides Treatment Decisions in Ovarian Cancer

05/12/2017

JCP Editors

New research shows that blocking poly (ADP-ribose) polymerase-1 (PARP-1) may have a greater impact than restoring BRCA1 for the treatment of ovarian cancer, according to research presented at the 2017 American...

New...

05/12/2017

Journal of Clinical Pathways

Research in Review

Lenalidomide Maintenance Prolongs PFS in Older Patients With Diffuse B-Cell Lymphoma

05/12/2017

JCP Editors

Lenalidomide maintenance therapy for 24 months after obtaining a complete or partial response to standard chemotherapy significantly prolongs progression-free survival (PFS) in older patients with diffuse large...

...

05/12/2017

Journal of Clinical Pathways

Research in Review

PD-1 Expression in T Cells Aids Immunotherapy Strategies for NSCLC

05/12/2017

JCP Editors

Early activation of programmed cell death-1 (PD-1) in CD8 T-cells after immunotherapy treatment is crucial to antitumor response for patients with non-small cell lung cancer (NSCLC), according to research published...

Early...

05/12/2017

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

May 2017

Feature

Column

Insights

Department

Current Issue

Special Reports

Subscribe

May 2017 Volume 3

Specialties

Events

Year Round Education

HMP Global Products